tiprankstipranks
Trending News
More News >
Herbalife Ltd (HLF)
NYSE:HLF
Advertisement

Herbalife (HLF) AI Stock Analysis

Compare
502 Followers

Top Page

HLF

Herbalife

(NYSE:HLF)

Rating:63Neutral
Price Target:
$10.00
▲(2.25% Upside)
Herbalife's overall stock score is driven by its undervalued valuation and strategic advancements highlighted in the earnings call. However, financial challenges, including declining revenues and high leverage, weigh heavily on the score. Technical indicators suggest a neutral market sentiment.
Positive Factors
Earnings
Expected share price return is 62.7%.
Leadership
New CEO Stephan Gratziani has a long-term vision and connects with top distributors, contributing positively to the company's future.
Negative Factors
Regional Performance
Total HLF new distributor growth remained solid at +16% Y/Y, but notably the N. America trend inflected negative compounding questions about the timeline for a US sales inflection.
Web Traffic
In the U.S., there has been a sharp reversal in the trend of average unique visitors and total web visits to myherbalife.com, which is now declining year over year.

Herbalife (HLF) vs. SPDR S&P 500 ETF (SPY)

Herbalife Business Overview & Revenue Model

Company DescriptionHerbalife Nutrition Ltd. offers nutrition solutions in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and rest of Asia Pacific. The company provides products in the areas of weight management; targeted nutrition; energy, sports, and fitness; and outer nutrition. It offers weight management products, including meal replacement products, protein shakes, drink mixes, weight loss enhancers, and healthy snacks; targeted nutrition products, which comprise functional beverages, and dietary and nutritional supplements that contain herbs, vitamins, minerals, and other natural ingredients; outer nutrition products, such as facial skin, body, and hair care products; and energy, sports, and fitness products, including N-R-G tea and energy drink products. The company also provides literature, promotional, and other materials that comprise start-up kits, sales tools, and educational materials. It offers its products through independent service providers and sales representatives, as well as through company-operated retail platforms. The company was formerly known as Herbalife Ltd. and changed its name to Herbalife Nutrition Ltd. in April 2018. Herbalife Nutrition Ltd. was founded in 1980 and is headquartered in Los Angeles, California.
How the Company Makes MoneyHerbalife generates revenue primarily through the sale of its products, which are distributed by independent distributors who earn commissions based on their sales and the sales of their recruits. This MLM structure creates multiple revenue streams: direct sales to consumers, commissions from distributor sales, and bonuses for distributors based on their sales performance and team sales. Additionally, Herbalife benefits from retail sales through its branded stores and online platforms. The company's earnings are also influenced by promotional partnerships and sponsorships within the fitness and wellness industries, reinforcing its brand presence and driving product demand.

Herbalife Earnings Call Summary

Earnings Call Date:Aug 06, 2025
(Q2-2025)
|
% Change Since: |
Next Earnings Date:Oct 29, 2025
Earnings Call Sentiment Neutral
The earnings call reflected a mix of strategic advancements and financial challenges. While the launch of new platforms and products, as well as operational efficiencies, were positive, the continued decline in net sales and volume, influenced by currency headwinds, presented challenges. The company is showing signs of recovery and growth, particularly in North America.
Q2-2025 Updates
Positive Updates
Launch of Pro2col Platform
Herbalife launched the beta version of the Pro2col platform, with over 7,000 distributors participating. This represents a significant step towards personalized, data-driven wellness solutions.
Introduction of New Products
New product launches included MultiBurn, a nonpharmaceutical weight loss supplement, and a healthy lifespan supplement. These products are expected to enhance the company's market presence.
Adjusted EBITDA Exceeds Guidance
Q2 adjusted EBITDA was $174 million, exceeding the high end of the guidance range, showcasing operational efficiency.
Debt Reduction
Herbalife paid down $55 million in debt during the quarter, maintaining a leverage ratio of 3x.
North America Volume Growth
July marked the first month of year-over-year volume growth in North America since April 2021, indicating positive regional momentum.
Negative Updates
Decline in Overall Net Sales
Net sales for Q2 were $1.3 billion, down 1.7% compared to Q2 of 2024, despite being within the guidance range.
Currency Headwinds
Unfavorable foreign exchange movements negatively impacted sales by approximately 170 basis points year-over-year.
Volume Decline in Key Markets
Volume was down 3.1% year-over-year, with notable declines in North America (6%) and China (6%).
Company Guidance
During the Herbalife Second Quarter 2025 Earnings Conference Call, the company provided updated guidance, highlighting several key metrics. Net sales for Q2 were reported at $1.3 billion, down 1.7% from Q2 2024, but flat on a constant currency basis. Despite this, the company achieved a solid adjusted EBITDA of $174 million, exceeding guidance, with an adjusted EBITDA margin of 13.8%. Herbalife also paid down $55 million in debt, maintaining a total leverage ratio of 3x as of June 30. The company noted a milestone in North America with year-over-year volume growth in July for the first time since April 2021. As a result of this progress, Herbalife raised and narrowed its full-year net sales guidance range. For Q3, net sales growth is projected to be between 0.5% and 4.5%. The call also emphasized the ongoing transformation into a data-driven wellness company, with the launch of the Pro2col app in North America, and the introduction of new products like MultiBurn and a healthy lifespan supplement.

Herbalife Financial Statement Overview

Summary
Herbalife's financial performance is mixed. Strong gross profit margins indicate efficient cost management, but declining revenue and net profit margins highlight challenges in sustaining growth. The balance sheet shows significant financial leverage and negative equity, posing risks to financial stability. Cash flow generation is stable, but high financing outflows suggest potential liquidity pressures.
Income Statement
70
Positive
Herbalife's income statement shows a declining trend in total revenue over the past few years, with a recent TTM total revenue of $4.95 billion, down from $5.20 billion in 2022. The gross profit margin remains strong at approximately 77.39% for the TTM period, indicating efficient cost management. However, the net profit margin has decreased to 5.66% from higher levels in previous years, highlighting challenges in maintaining profitability. The EBIT margin for TTM stands at 9.08%, and EBITDA margin at 10.64%, both reflecting a stable yet pressured operating environment.
Balance Sheet
45
Neutral
The balance sheet reveals significant financial leverage, with a negative stockholders' equity of -$736 million as of TTM, indicating high debt levels relative to assets. The debt-to-equity ratio is not calculable due to negative equity, raising concerns about financial stability. The equity ratio is also negative, further emphasizing the risk associated with high indebtedness. Despite these challenges, total assets remain substantial at $2.68 billion.
Cash Flow
65
Positive
Herbalife's cash flow statement shows a modest free cash flow growth, with TTM free cash flow of $164.4 million, slightly higher than the previous year's $163.4 million. The operating cash flow to net income ratio is 0.97, indicating efficient cash conversion from net income. However, the high levels of financing cash outflows raise concerns about reliance on debt to fund operations.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue4.93B4.99B5.06B5.20B5.80B5.54B
Gross Profit3.85B3.89B3.87B4.03B4.56B4.39B
EBITDA620.10M509.10M482.20M672.70M854.60M740.90M
Net Income325.00M254.30M142.20M321.30M447.20M372.60M
Balance Sheet
Total Assets2.74B2.73B2.81B2.73B2.82B3.08B
Cash, Cash Equivalents and Short-Term Investments320.90M415.30M575.20M508.00M601.50M1.05B
Total Debt2.35B2.47B2.77B2.88B2.96B2.64B
Total Liabilities3.39B3.53B3.87B4.00B4.21B3.93B
Stockholders Equity-660.50M-801.10M-1.06B-1.27B-1.39B-856.10M
Cash Flow
Free Cash Flow171.40M163.40M222.50M196.10M308.90M516.60M
Operating Cash Flow265.30M285.40M357.50M352.50M460.30M628.60M
Investing Cash Flow-85.00M-84.60M-134.80M-156.20M-156.40M-123.20M
Financing Cash Flow-227.50M-335.30M-148.30M-264.70M-728.60M-320.90M

Herbalife Technical Analysis

Technical Analysis Sentiment
Positive
Last Price9.78
Price Trends
50DMA
9.34
Positive
100DMA
8.27
Positive
200DMA
7.81
Positive
Market Momentum
MACD
0.06
Negative
RSI
54.95
Neutral
STOCH
44.20
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HLF, the sentiment is Positive. The current price of 9.78 is above the 20-day moving average (MA) of 9.34, above the 50-day MA of 9.34, and above the 200-day MA of 7.81, indicating a bullish trend. The MACD of 0.06 indicates Negative momentum. The RSI at 54.95 is Neutral, neither overbought nor oversold. The STOCH value of 44.20 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HLF.

Herbalife Risk Analysis

Herbalife disclosed 34 risk factors in its most recent earnings report. Herbalife reported the most risks in the "Legal & Regulatory" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Herbalife Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
80
Outperform
$297.16M22.599.15%4.33%-6.33%
71
Outperform
$2.88B20.028.22%14.22%-1.81%
70
Outperform
$583.05M17.706.54%2.75%-37.25%
69
Neutral
$2.11B16.608.70%-4.90%0.29%
68
Neutral
$2.17B26.008.79%2.80%0.50%-4.46%
63
Neutral
$1.01B3.08-31.74%-2.25%288.79%
63
Neutral
$20.44B14.73-2.94%3.07%2.04%-6.12%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HLF
Herbalife
9.78
1.72
21.34%
CENT
Central Garden Pet
36.43
-2.82
-7.18%
JJSF
J & J Snack Foods
111.57
-55.35
-33.16%
SMPL
Simply Good Foods
28.63
-3.66
-11.33%
NATR
Nature's Sunshine Products
16.85
3.10
22.55%
USNA
USANA Health
31.91
-7.51
-19.05%

Herbalife Corporate Events

Product-Related AnnouncementsBusiness Operations and StrategyFinancial Disclosures
Herbalife Reports Q2 2025 Financial Results and Innovations
Positive
Aug 6, 2025

Herbalife reported its financial results for the second quarter of 2025, with net sales of $1.3 billion, slightly down by 1.7% compared to the previous year, impacted by foreign currency headwinds. The company exceeded its adjusted EBITDA guidance and raised its full-year net sales and adjusted EBITDA outlook. Recent developments include the launch of MultiBurn, a new weight-loss supplement, and the unveiling of the beta version of the Pro2col app, indicating a focus on innovation and expanding product offerings. These initiatives, along with strong distributor engagement programs, are expected to drive future growth and enhance Herbalife’s market position.

Private Placements and FinancingFinancial Disclosures
Herbalife Announces Redemption of Senior Notes
Neutral
Jun 16, 2025

On June 10, 2025, Herbalife Ltd. and its subsidiary issued a notice to redeem $50 million of their 7.875% Senior Notes due 2025. The redemption is scheduled for June 30, 2025, at a price of $1,000 per $1,000 principal amount, impacting the company’s financial obligations and potentially its market positioning.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 19, 2025